LZAGY
Lonza Group Ag Zuerich Unsponsored ADR (LZAGY) [ST]
▼ 3.69%
prev close
LONZA GROUP AG UNSP/ADR
Congressional Trades
2
All tracked trades
Members Trading
2
Unique members
Net Activity
-2
0 buys · 2 sells
Members Who Traded This Stock
2 trade events
| Date | Member | Stock | Type | Amount | Filed | Signal |
|---|---|---|---|---|---|---|
| 2023-12-21 | LZAGYLonza Group Ag Zuerich Unsponsored ADR | Sell | $1,001 - $15,000 | 927d ago | — | |
| 2023-07-10 | LZAGYLonza Group Ag Zuerich Unsponsored ADR | Sell | $15,001 - $50,000 | 1074d ago | — |
2023-12-21
Josh Gottheimer
LZAGY
Amount
$1,001 - $15,000
Filed
927d ago
2023-07-10
Daniel Goldman
LZAGY
Amount
$15,001 - $50,000
Filed
1074d ago
Recent News
Powered by Polygon.io
Oligonucleotide CDMO Market to Reach USD 9.87 Billion by 2031 as RNA-Targeted Drug Pipelines Expand
[Latest] Global Beadlets Capsule Market Size/Share Worth USD 968.45 Million by 2035 at a 6.85% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
Global CRISPR-Based Drug Development Platforms Market to Reach USD 0.79 Billion by 2031: Precision Medicine and Gene Therapy Drive Growth
Global Cell and Gene Therapy CDMO Market Anticipating Remarkable Growth at a CAGR of ~24% by 2034 | DelveInsight
Protein Synthesis Research Market to Reach $42.8 Billion by 2031, Driven by Surging CGT Investment
Trade Timeline
Congressional activity, newest first
Josh Gottheimer
2023-12-21 · Sale
$1,001 - $15,000
Daniel Goldman
2023-07-10 · Sale
$15,001 - $50,000